Dermatology

Diffuse Parenchymal Lung Disease

Questions discussed in this category

In elderly patients with advanced melanoma and idiopathic pulmonary fibrosis receiving active antifibrotic therapy, would neoadjuvant or adjuvant immune checkpoint inhibition be preferred?

3 Answers available

Papers discussed in this category

The New England journal of medicine, 2017-11-09

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.

The New England journal of medicine, 2024 Jun 19

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

Cancer, 2024 Jun 06

Long-term efficacy of neoadjuvant-adjuvant targeted therapy in borderline resectable stage IIIB-D and IV melanoma.

Related Topics in Dermatology